Nuria García

Nuria García is the current head of cosmeceutical development at Antalgenics. Prior to this, they worked as an open innovation specialist at Lipotec Srl from April 2016 to March 2018. From January 2014 to December 2016, they were the new technologies and IP manager at Lipotec. From January 2005 to December 2013, García worked as a project leader at DiverDrugs, SL. Nuria began their career as a researcher at Universidad Miguel Hernández de Elche from January 2001 to December 2005, where they characterized molecular receptors involved in nociception.

Nuria García has a doctorate in molecular and cellular biology from Universidad Miguel Hernández de Elche, and a degree in biochemistry from the same school. Nuria also has a degree in chemistry from Universitat d'Alacant.

They work with Isabel Devesa - Chief Scientific Officer, Ana Espinosa - Operations Manager, and Ana María Sempere - Laboratory Manager & Project Leader. Nuria García reports to Antonio Ferrer Montiel, President.